Most were designed for the general market, not for a body with reduced appetite, altered taste, slowed digestion, and a focus on blood sugar
Start your intake How Semaglutide Levels Drop Throughout Your Week When you inject semaglutide once weekly, the medication doesn't stay at one constant level in your bloodstream
Regional Insights North America GLP-1 Receptor Agonist Market Trends North America dominates the GLP-1 receptor agonist market with a 41.8% share in 2025 , driven by the high prevalence of diabetes and obesity, coupled with strong healthcare infrastructure and widespread insurance coverage
18 to March 3 and May 28 to June 5, 2026
Mounjaro (tirzepatide), Wegovy (semaglutide), Saxenda (liraglutide), and oral semaglutide (Rybelsus) all have phase 3 trial data showing meaningful weight loss when used alongside lifestyle change
Researchers determined more than 2,000 people would need to be treated with a GLP-1 receptor agonist to reduce one persons risk for colorectal cancer